UnknownNot Applicable

Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments

United States8 participantsStarted 2012-12

Plain-language summary

This is an observational research study whose purposes are to see the effects of repeated hyperbaric oxygen therapy treatments on the levels of stem/progenitor cells in peripheral circulating blood following five days of treatment, 90 minutes per day at 2.0 atmospheres absolute in 100% USP Grade Oxygen. Hyperbaric oxygen has a greater oxygen concentration than air at sea level. In this research, the concentration of oxygen will be twice the level of oxygen at sea level.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients recruited will be healthy volunteers with no current, ongoing infection or chronic disease. Exclusion Criteria: We will exclude or delay the treatment if our patients have an active lung infection, develops cancer, if the patient cannot undergo pressurization/ depressurization because of eustachian-tube dysfunction and confinement anxiety. Any patient that cannot breathe without a respirator will be excluded.

What they're measuring

Peripheral blood analysis of circulating stem cells

Timeframe: 5 days

Trial details

NCT IDNCT01740908

SponsorRestorix Research Institute, LLLP

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-12

View on ClinicalTrials.gov More Changes in Peripheral Blood Population Numbers and Type. trials